The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALUMIS INC | COM | 022307102 | 8,229,375 | 618,750 | SH | SOLE | 618,750 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | COM SHS | G29687103 | 6,049,245 | 430,245 | SH | SOLE | 430,245 | 0 | 0 | ||
| BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 3,891,100 | 835,000 | SH | SOLE | 835,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 8,152,264 | 75,638 | SH | SOLE | 75,638 | 0 | 0 | ||
| CG ONCOLOGY INC | COM | 156944100 | 5,520,835 | 174,876 | SH | SOLE | 174,876 | 0 | 0 | ||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 3,781,895 | 1,886,232 | SH | SOLE | 1,886,232 | 0 | 0 | ||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 7,387,389 | 536,095 | SH | SOLE | 536,095 | 0 | 0 | ||
| DISC MEDICINE INC | COM | 254604101 | 7,504,155 | 166,500 | SH | SOLE | 166,500 | 0 | 0 | ||
| ELIEM THERAPEUTICS INC | COM | 28658R106 | 3,555,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 11,603,451 | 2,736,663 | SH | SOLE | 2,736,663 | 0 | 0 | ||
| INSMED INC | COM PAR $.01 | 457669307 | 8,643,000 | 129,000 | SH | SOLE | 129,000 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 4,962,538 | 218,614 | SH | SOLE | 218,614 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 6,316,230 | 306,762 | SH | SOLE | 306,762 | 0 | 0 | ||
| LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 8,636,550 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| LONGBOARD PHARMACEUTICALS IN | COM | 54300N103 | 5,919,056 | 218,981 | SH | SOLE | 218,981 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 10,345,519 | 174,844 | SH | SOLE | 174,844 | 0 | 0 | ||
| MIND MEDICINE MINDMED INC | COM NEW | 60255C885 | 6,960,721 | 965,426 | SH | SOLE | 965,426 | 0 | 0 | ||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 3,950,533 | 396,242 | SH | SOLE | 396,242 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | 6,343,755 | 153,379 | SH | SOLE | 153,379 | 0 | 0 | ||
| PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 1,589,373 | 1,059,582 | SH | SOLE | 1,059,582 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 11,613,000 | 73,500 | SH | SOLE | 73,500 | 0 | 0 | ||
| SOLENO THERAPEUTICS INC | COM | 834203309 | 11,675,410 | 286,162 | SH | SOLE | 286,162 | 0 | 0 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 4,395,279 | 1,474,926 | SH | SOLE | 1,474,926 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 4,231,913 | 264,660 | SH | SOLE | 264,660 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 6,603,697 | 169,369 | SH | SOLE | 169,369 | 0 | 0 | ||